MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
69.85%
Quick Ratio
69.85%
Cash Ratio
51.92%
Debt to Asset Ratio
131.61%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Property and equipment, net
Refundable research income tax c...
Others
Liabilities Breakdown
Accumulated deficit
Additional paid-in capital
Long-term portion of lease liabi...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
27,586
20,948
29,616
38,344
Restricted cash
-
-
912
-
Accounts receivable
873
371
523
372
Refundable research income tax credits
5,491
10,142
4,602
4,604
Prepaid expenses and other current assets
3,164
4,369
8,423
6,573
Total current assets
37,114
35,830
44,076
49,893
Restricted cash
-
0
0
1,500
Property and equipment, net
10,317
11,042
14,794
15,733
Operating lease right-of-use assets
2,905
3,064
14,428
15,061
Refundable research income tax credits, non-current
8,759
8,938
14,474
14,481
Other non-current assets
870
871
871
890
Total assets
59,965
59,745
88,643
97,558
Accounts payable
19,307
14,437
15,556
10,740
Accrued compensation and employee benefits
18,341
17,721
17,145
15,425
Other accrued liabilities
15,084
9,409
9,868
13,938
Deferred revenues
402
899
7,556
7,556
Total current liabilities
53,134
42,466
50,125
47,659
Deferred revenues, non-current
5,874
5,874
5,874
5,874
Long-term portion of lease liabilities
19,332
25,093
25,424
23,461
Other non-current liabilities
580
580
977
962
Total liabilities
78,920
74,013
82,400
77,956
Preferred stock
0
-
0
0
Common stock
4,143
3,507
3,220
2,728
Additional paid-in capital
1,637,659
1,610,938
1,594,298
1,573,233
Accumulated deficit
-1,658,244
-1,627,249
-1,589,830
-1,554,900
Accumulated other comprehensive loss
-2,513
-1,464
-1,445
-1,459
Total stockholders deficit
-18,955
-14,268
6,243
19,602
Total liabilities and stockholders deficit
59,965
59,745
88,643
97,558
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$27,586K
Refundable research income
tax credits
$5,491K
Prepaid expenses and
other current assets
$3,164K
Accounts receivable
$873K
Total current assets
$37,114K
Property and equipment,
net
$10,317K
Refundable research income
tax credits,...
$8,759K
Operating lease
right-of-use assets
$2,905K
Other non-current
assets
$870K
Total assets
$59,965K
Accumulated deficit
-$1,658,244K
Accumulated other
comprehensive loss
-$2,513K
Total liabilities and
stockholders deficit
$59,965K
Total stockholders
deficit
-$18,955K
Additional paid-in capital
$1,637,659K
Common stock
$4,143K
Total liabilities
$78,920K
Total current
liabilities
$53,134K
Long-term portion of lease
liabilities
$19,332K
Deferred revenues,
non-current
$5,874K
Other non-current
liabilities
$580K
Accounts payable
$19,307K
Accrued compensation
and employee...
$18,341K
Other accrued
liabilities
$15,084K
Deferred revenues
$402K
Buy us a coffee
SANGAMO THERAPEUTICS, INC (SGMO)
SANGAMO THERAPEUTICS, INC (SGMO)